First Horizon Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

First Horizon Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,152	Closed	-$7K	–	1516
2020 Q1	$7K	Hold	1,152	–	–	﹤0.01%	1053
2019 Q4	$27K	Hold	1,152	–	–	﹤0.01%	759
2019 Q3	$30K	Buy	1,152 +189	+20%	+$5.31K	﹤0.01%	713
2019 Q2	$25K	Hold	963	–	–	﹤0.01%	808
2019 Q1	$33K	Buy	+963	New	+$27.8K	﹤0.01%	640

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

First Horizon Advisors's PTLA Position: Q2 2020 in Review

First Horizon Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 1,152 shares — an estimated $7K sold.

First Horizon Advisors first reported a position in PTLA in Q1 2019 and held it in 5 quarters. The position peaked at $33K in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

First Horizon Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
First Horizon Advisors sold 1,152 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $7K.
First Horizon Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q1 2019 and held it in 5 quarters.
First Horizon Advisors's Portola Pharmaceuticals, Inc. position peaked at $33K in Q1 2019.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on First Horizon Advisors's 13F filing for Q2 2020, filed 31 Jul 2020.